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OBJECTIVES We sought to determine whether potassium (K) channel blockers (KBs) can activate
extracellular signal-regulated kinase (ERK) and to characterize the upstream signals leading
to ERK activation in cardiomyocytes.
BACKGROUND Because KBs attenuate K outward current, they may possibly prolong the duration of action
potentials, leading to an increase in calcium (Ca2) transient ([Ca2]i) in cardiomyocytes.
Elevation of intracellular Ca2 levels can trigger various signaling events. Influx of Ca2
through L-type Ca2 channels after membrane depolarization induced activation of MEK
and ERK through activation of Ras in neurons. Although KBs are frequently used to treat
cardiac arrhythmias, their effect on signaling pathways remains unknown.
METHODS Primary cultured rat cardiomyocytes were stimulated with four different KBs— 4-
aminopyridine (4-AP), E-4031, tetra-ethylammonium and quinidine—and phosphorylation
of ERK, proline-rich tyrosine kinase 2 (Pyk2) and epidermal growth factor receptor (EGFR)
was detected. Action potentials were recorded by use of a conventional microelectrode.
(Ca2)i was monitored by the fluorescent calcium indicator Fluo-4.
RESULTS E-4031, 4-AP, tetra-ethylammonium and quinidine induced phosphorylation of ERK.
4-Aminopyridine prolonged the duration of action potentials by 37% and increased (Ca2)i
by 52% at 1 mmol/l. Pre-incubation of ethyleneglycoltetraacetic acid, 1,2-bis(2-
aminophenoxy)-ethane-N,N,N,N-tetraacetic acid tetrakis and diltiazem completely
blocked this phosphorylation, whereas flufenamic acid and benzamil did not.
4-Aminopyridine induced tyrosine phosphorylation of Pyk2 and EGFR, which peaked at 5
and 10 min, respectively. Cytochalasin D, AG1478 and dominant-negative EGFR strongly
inhibited the phosphorylation of ERK, whereas calphostin C, calmidazolium and KN62 did
not.
CONCLUSIONS These findings indicate that KBs induce ERK activation, which starts with Ca2 entry
through the L-type Ca2 channel in cardiomyocytes, and that EGFR and Pyk2 are involved
in this activation. (J Am Coll Cardiol 2001;38:1554–63) © 2001 by the American College
of Cardiology
Since the Cardiac Arrhythmia Suppression Trial was re-
ported, sodium (Na) channel blockers have been consid-
ered to deteriorate the prognosis of patients with cardiac
arrhythmias. Sodium channel blockers decrease Na entry,
which, in turn, decreases calcium (Ca2) influx through
L-type Ca2 channels. Consequently, the decreased Ca2
influx has a negative inotropic effect on cardiomyocytes. In
contrast, potassium (K) channel blockers (KBs) were
expected to be used more frequently than before. Recent
studies have demonstrated that KBs inhibit K outward
current, which, in turn, causes prolongation of action
potentials. Prolongation of action potentials results in a
substantial increase in net Ca2 entry through L-type Ca2
channels, and this augmented Ca2 influx enhances myo-
cardial contractility by increasing Ca2 release from the
sarcoplasmic reticulum (1,2). Potassium channel blockers,
such as 4-aminopyridine (4-AP), which block K outward
currents and prolong the action potential duration (APD),
increase Ca2 transient ([Ca2]i) in cardiomyocytes (3,4).
These data indicate that KBs could exert potentiating effects
on contractility by increasing the amplitude of intracellular
[Ca2]i.
Mitogen-activated protein kinase (MAPK) family pro-
teins transduce signal from diverse receptor types, including
receptor protein tyrosine kinases, G-protein-coupled recep-
tors and cytokine receptors, and play an important role in
the proliferation and differentiation of various cell types
(5,6). Among this family, extracellular signal-regulated
kinase (ERK) has been reported to be activated by various
cytokines and growth factors, such as phenylephrine,
endothelin-1, angiotensin II and leukemia inhibitory factor
(7), as well as by mechanical stretching in cardiomyocytes.
The activation of ERK requires phosphorylation of both a
threonine and a tyrosine residue by a dual-specificity kinase
known as MEK (MAPK/ERK kinase). Activated ERK
translocates into the nucleus and can phosphorylate a variety
of nuclear transcription factors, suggesting that ERK is a
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key mediator of transduction of cytoplasmic signals to
nuclear responses.
Elevation of intracellular Ca2 levels can trigger various
signaling events. Rosen et al. (8) reported that Ca2 influx
through L-type voltage-dependent Ca2 channels after
membrane depolarization induced activation of MEK and
MAPK through activation of Ras in neurons. Moreover,
Ca2 influx after membrane depolarization was recently
reported to mediate ligand-independent transactivation of
epidermal growth factor receptor (EGFR) in PC12 cells
(9,10). Subsequently, we directed our attention to KBs and
investigated whether the use of KBs can activate the ERK
pathway through Ca2-dependent signaling. Moreover, we
also explored the upstream signals leading to ERK activa-
tion by KBs. Here, we report that KBs can induce ERK
activation, which is initiated by Ca2 entry through L-type
Ca2 channels, and that EGFR and proline-rich tyrosine 2
(Pyk2) are critically involved in KB-induced ERK activation
in cardiomyocytes.
METHODS
Cell culture. Primary cultures of cardiomyocytes were
prepared from the ventricles of one-day-old neonatal Wistar
rats, as described previously (11). At 48 h after seeding, the
culture medium was changed to medium containing 0.5%
fetal bovine serum, incubated for 6 h, and then KBs were
added.
Recording of action potentials. Electrophysiologic studies
were performed in Tyrode’s solution with 0.5% fetal bovine
serum, under various concentrations (0, 0.1 and 1 mmol/l)
of 4-AP, which was dissolved in distilled water immediately
before use. Cultured cells were plated on the stage of an
inverted phase-contrast microscope (Diaphoto-300, Nikon,
Toyko, Japan) at 37°C. Action potentials were recorded by
use of a conventional microelectrode. Glass microelectrodes
filled with potassium chloride (3 mol/l), with a direct
current resistance of 15 to 30 M, were selected. Mem-
brane potentials were measured in the current clamp mode
(MEZ-8300, Nihon Kohden, Tokyo, Japan) and stored on
digital magnetic tape (frequency range 0 to 20 kHz; Sony
Magnescale, Sony Co., Tokyo, Japan) for later analysis.
During measurements, the cells were field-stimulated by
7-ms pulses at 1 Hz with a step-pulse generator (SET-
1201, Nihon Kohden, Tokyo, Japan).
Measurement of [Ca2]i. The [Ca
2]i transient was mon-
itored by use of the fluorescent calcium indicator Fluo-4
(Molecular Probes, Eugene, Oregon), as described previ-
ously (12). During measurements, the cells were field-
stimulated by 7-ms pulses at 1 Hz.
Reagents and antibodies. Potassium channel blockers,
including 4-AP, 1-(2-[6-methyl-2-pyridil]-ethyl)-4-(4-
methylsulfonylaminobenzoyl)-piperidine (E-4031, Eisai,
Tokyo, Japan), tetra-ethylammonium (TEA) and quini-
dine, were purchased from Sigma Chemical Co., Ltd.
(Tokyo, Japan). Anti-phospho-ERK antibody was pur-
chased from New England Biolabs (Boston, Massachu-
setts). Anti-phosphotyrosine antibody (RC20H) was pur-
chased from Transduction Laboratories (Lexington,
Kentucky). Anti-Pyk2 and anti-EGFR antibodies were
purchased from Santa Cruz Biotechnology, Inc. (Santa
Cruz, California).
Immunoprecipitation and Western blot analysis. The
cells were lysed with a buffer, as described previously (7).
Lysates were incubated with either anti-EGFR or anti-
Pyk2 antibody at 4°C for 4 h, followed by protein A- or
G-sepharose (Sigma) for 2 h, and immunoprecipitated.
Proteins were separated by 6% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and im-
munoblotted with anti-phosphotyrosine antibody. Western
blot analysis for phospho-ERK was performed, as described
previously (7). The signals were visualized by enhanced
chemiluminescence (Amersham Pharmacia Biotech, Buck-
inghamshire, England).
Transfection of plasmids and in vitro kinase assay.
Tranasfection of plasmids was performed using effectene
transfection reagent (Qiagen, Hilden, Germany), according
to the manufacturer’ s instructions. The deletion mutant
(533del) of human EGFR (EGFRdel) was provided by
Murasawa et al. (13). Hemaggulutinin-tagged ERK2 plas-
mid (HA-ERK2) with the SV40 promoter was provided by
Minden et al. (14). HA-ERK2 was co-transfected with
these plasmids. After 4-AP treatment, the cells were lysed,
and the lysates were incubated with anti-HA antibody
(Santa Cruz Biotechnology, Inc.). The immunocomplex
was precipitated on protein A-sepharose, resuspended in 25
l of kinase buffer and incubated with 25 g of bovine
myelin basic protein (Sigma) as a substrate at 30°C for
20 min. The reaction was terminated by adding Laemmli
sample buffer. The supernatants were resolved by SDS-
PAGE, and the gel was washed with 5% trichloroacetic acid
for 30 min, dried and subjected to auto-radiography.
Abbreviations and Acronyms
4-AP  4-aminopyridine
APD  action potential duration
BAPTA-AM  1,2-bis(2-aminophenoxy)-ethane-
N,N,N,N-tetraacetic acid tetrakis
Ca2  calcium
[Ca2]i  Ca
2 transient
EGFR  epidermal growth factor receptor
ERK  extracellular signal-regulated kinase
HA  hemaggulutinin
K  potassium
KB  potassium channel blocker
LIF  leukemia inhibitory factor
MAPK  mitogen-activated protein kinase
MEK  MAPK/ERK kinase
Na  sodium
PKC  protein kinase C
Pyk2  proline-rich tyrosine 2
TEA  tetra-ethylammonium
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Statistical analysis. The data were processed using Stat-
View J-4.5 software. All data are expressed as the mean
value  SE. Comparisons among the values of all groups
(Figs. 1 to 6) were performed by one-way analysis of
variance. For comparisons of myelin basic protein kinase
activities among all groups in the transfection experiments,
two-way analysis of variance was performed. The Bonfer-
roni method was used to determine the level of significance.
A p value 0.05 was considered statistically significant.
RESULTS
4-Aminopyridine prolongs the APD in cardiomyocytes.
To begin to determine whether KBs can activate Ca2-
mediated signaling in cardiomyocytes, we needed to deter-
mine precisely how KBs can affect action potentials.
4-Aminopyridine is known to inhibit Ito and Ikur, which
may culminate in the prolongation of action potentials. We
first recorded the action potentials of cardiomyocytes stim-
Figure 1. 4-Aminopyridine (4-AP) prolonged the action potential duration (APD) in cardiomyocytes. Action potentials of the cardiomyocytes were
recorded as described in the Methods section, using a conventional glass micropippete, and the cells were treated with 4-AP (0.1 and 1 mmol/l) for 5 min.
(A) Representative tracings of the action potentials. These tracings were obtained from the same cells. (B) Effect of 4-AP on the APD90. The experiments
were repeated three times, and the data are presented as the mean value  SE obtained from 15 different cells. 4-Aminopyridine increased the APD by
37% at 1 mmol/l. *p  0.01 vs. control cells. NS  not significant.
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ulated by various concentrations of 4-AP (0, 0.1 and
1 mmol/l). Figure 1A shows a representative tracing of the
action potentials. Figure 1B indicates the effect of 4-AP on
the APD90 obtained from seven separate experiments.
4-Aminopyridine prolonged APD90 in a dose-dependent
manner. One mmol/l of 4-AP lengthened APD90 by 37%.
4-Aminopyridine increases intracellular [Ca2]i. Prolon-
gation of action potentials suggested that 4-AP may in-
crease [Ca2]i in cardiomyocytes. To confirm this, we
measured [Ca2]i in the cells stimulated by 4-AP (0.1 and
1 mmol/l). Figure 2A shows a representative tracing, and
Figure 2B shows the time course of [Ca2]i of the cardio-
myocytes treated with 1 mmol/l of 4-AP. 4-Aminopyridine
prominently increased [Ca2]i. 4-Aminopyridine
(1 mmol/l) enhanced [Ca2]i at 1 min and caused it to peak
at 10 min, by 152  0.5%.
KBs activate ERK in cardiomyocytes. The activation of
ERK represents a point of convergence for growth signals
originating from different type of receptors, such as
G-protein-coupled receptors, tyrosine kinase receptors and
cytokine receptors (6). To address the possibility that the
use of KBs can affect intracellular signaling pathways
through [Ca2]i in cardiomyocytes, we first investigated
whether KBs can activate ERK. We incubated cardiomyo-
cytes with either 4-AP (1 mmol/l), E4031 (2 mol/l), TEA
(10 mmol/l) or quinidine (50 mol/l) for up to 30 min (Fig.
3A to 3D). Interestingly, all KBs induced phosphorylation
of ERK in a time-dependent manner, which peaked at
15 min. We also stimulated the cells with leukemia inhib-
itory factor (LIF) as a positive control agent (Fig. 3E).
These findings indicate that KBs could induce ERK acti-
vation to the same extent as LIF.
The KBs may affect the different K channels at different
concentrations and prolong the APD at certain concentra-
tions. To determine the dose dependency of KBs on ERK
activation, we stimulated the cells with various concentra-
tions (0.01 to 1 mmol/l) of 4-AP and detected the phos-
phorylation of ERK. 4-Aminopyridine phosphorylated
ERK in a dose-dependent manner (Fig. 3F).
Involvement of an L-type Ca2 channel-mediated in-
crease in [Ca2]i on KB-mediated ERK activation.
Next, we investigated the molecular mechanism leading to
the activation of ERK by KBs. Because KBs are not
physiologic ligands, and the aforementioned findings sug-
gest that application of KBs significantly modulates intra-
cellular Ca2 in cardiomyocytes, we investigated the possi-
ble involvement of Ca2 in KB-mediated ERK activation.
We pre-incubated the cells with egtazic acid (1 mmol/l) and
Figure 2. 4-Aminopyridine (4-AP) enhances calcium transient [Ca2]i in cardiomyocytes. Cardiomyocytes were pretreated with Fluo-4 and treated with
4-AP for the indicated times. [Ca2]i was recorded as described in Methods. (A) Representative tracings of [Ca
2]i. The tracings were recorded from the
same cells. The cells were treated with 1 mmol/l of 4-AP for 10 min. (B) The time course of [Ca2]i. One mmol/l of 4-AP increased [Ca
2]i by 52% at
10 min. The experiments were repeated three times, and the data are presented as the mean value  SE obtained from 15 different cells. *p  0.01 and
**p  0.05 vs. control cells.
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1,2-bis(2-aminophenoxy)-ethane-N,N,N,N-tetraacetic
acid tetrakis (BAPTA-AM) (20 mol/l), and we detected
the phosphorylation of ERK. Interestingly, 4-AP-induced
ERK activation was completely abrogated by egtazic acid
and BAPTA-AM (Fig. 4A). Next, we investigated the
involvement of the voltage-dependent L-type Ca2 chan-
nel, nonselective cation channel and Na/Ca2 exchanger.
We pre-incubated the cells with the L-type Ca2 channel
blocker diltiazem (2 mol/l), the nonselective cation chan-
nel blocker flufenamic acid (100 mol/l) and the Na/Ca2
exchanger blocker benzamil (100 mol/l), and we detected
ERK phosphorylation. Diltiazem almost completely inhib-
ited the phosphorylation of ERK, whereas benzamil and
flufenamic acid had no effect on this phosphorylation (Fig.
4B and 4C). To confirm that the augmentation of L-type
Ca2 current directly activates this phosphorylation, we
stimulated the cells with the L-type channel opener
Bayk8644 (10 mol/l), and we detected the phosphoryla-
tion of ERK. Bayk8644 induced phosphorylation of ERK in
a time-dependent manner (Fig. 4D). Figure 4E shows the
densitometric analysis of the mean expression of phosphor-
ylated ERK in five separate experiments. These findings
indicate that 4-AP-induced phosphorylation of ERK was
mediated by voltage-dependent L-type Ca2 channels.
Involvement of Pyk2 and EGFR in K channel blocker-
induced ERK activation. The involvement of L-type
Ca2 current and Ca2-induced Ca2 release suggests that
Ca2-binding protein may take part in this ERK activation.
Protein kinase C (PKC), calmodulin-dependent kinases and
Pyk2 are Ca2-dependent and are considered to be located
upstream of ERK in various types of cells (13,15,16).
Therefore, we pre-incubated the cells with calphostin C
(PKC inhibitor; 1 mol/l), calmidazolium (calmodulin
inhibitor; 50 mol/l), KN62 (CaMKII and IV inhibitor;
10 mol/l) and cytochalasin D (10 mol/l), and we mea-
sured the phosphorylation of ERK. Cytochalasin D is an
inhibitor of actin polymerization, and other investigators
have observed that this compound can inhibit the activation
of Pyk2 (17,18). Because EGFR plays a critical role in
mediating ERK activation evoked by various ligands and is
considered to be parallel to or downstream of Ca2-binding
protein, we investigated the possible involvement of EGFR.
We pre-incubated the cells with the specific EGFR inhib-
itor AG1478 (250 nmol/l), and we measured ERK phos-
phorylation. Figure 5A and 5B shows the representative blot
analysis, and Figure 5C shows the densitometric analysis
obtained from four separate experiments. Calphostin C,
calmidazolium and KN62 did not inhibit the 4-AP-induced
Figure 3. Potassium channel blockers activate extracellular signal-regulated kinase (ERK) in cardiomyocytes. Cardiomyocytes were treated with (A)
4-aminopyridine (4-AP) (1 mmol/l), (B) E4031 (2 mol/l), (C) tetraethylammonium (TEA) (10 mmol/l) and (D) quinidine (50 mol/l) for the indicated
times, and phosphorylation of ERK was detected by Western blot analysis. All potassium channel blockers induced phosphorylation of ERK, which peaked
at 15 min. (E) Leukemia inhibitory factor (LIF) was used as a positive control agent. (F) 4-Aminopyridine caused dose-dependent augmentation of the
phosphorylation of ERK in cardiomyocytes. The cells were treated with 0.01, 0.1 and 1 mmol/l of 4-AP for 15 min. All experiments were repeated at least
four times and gave similar results.
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activation of ERK. However, both cytochalasin D and
AG1478 strongly inhibited this phosphorylation. These
findings suggest that 4-AP-induced ERK activation could
be regulated through activation of EGFR and Pyk2.
4-Aminopyridine induces phosphorylation of Pyk2 and
EGFR. To confirm whether 4-AP really activated Pyk2 or
EGFR, or both, we performed immunoprecipitation-
Western blot analysis to detect tyrosine phosphorylation of
these two kinases. Pyk2 was phosphorylated as early as
2 min and peaked at 5 min (Fig. 6A). In addition, EGFR
was phosphorylated as early as 5 min and peaked at 10 min
after 4-AP stimulation (Fig. 6B). These results were repro-
ducible in four separate experiment. These findings impli-
cate Pyk2 and EGFR in 4-AP-induced activation of ERK
in cardiomyocytes.
Deletion mutant of EGFR inhibits 4-AP-induced ERK
activation. To confirm that EGFR is critically involved in
4-AP–induced ERK activation, we co-transfected HA-
tagged ERK2 plasmid with either an EGFR deletion
mutant or an empty plasmid and treated it with 4-AP.
Figure 4. Involvement of calcium (Ca2) and L-type Ca2 channels in 4-aminopyridine (4-AP)-induced ERK activation. (A) Cardiomyocytes were
pretreated with ethyleneglycoltetraacetic acid (EG) (1 mmol/l) or BAPTA-AM (BAP) (20 mol/l) for 30 min and treated with 4-AP (1 mmol/l) for
15 min. Both EG and BAPTA-AM completely abolished 4-AP-induced extracellular signal-regulated kinase (ERK) phosphorylation. (B) The cells were
pretreated with the L-type Ca2 channel blocker diltiazem (Dil) (2 mol/l) and the Na/Ca2 exchanger inhibitor benzamil (BZ) (100 mol/l) for 5 min,
and then treated with 4-AP for 15 min. Diltiazem fully inhibited ERK phosphorylation, whereas BZ did not. (C) The cells were pre-incubated with the
nonselective cation channel blocker fulfenamic acid (FA) (100 mol/l) and then treated with 4-AP for 15 min. Fulfenamic acid was dissolved in ethanol
(vehicle). Fulfenamic acid did not attenuate 4-AP-induced ERK activation. (D) The cells were treated with the L-type Ca2 channel opener Bayk8644
(10 mol/l) for the indicated times. BayK8644 induced phosphorylation of ERK. All experiments were repeated at least five times, and we obtained similar
results. (E) Densitometric analysis of the phosphorylation of ERK was shown. Data are presented as the mean value SE. *p 0.01 vs. 4-AP alone. LIF
leukemia inhibitory factor; NS  not significant.
1559JACC Vol. 38, No. 5, 2001 Tahara et al.
November 1, 2001:1554–63 KB-Evoked Signals in Cardiomyocytes
Activation of ERK was almost completely inhibited by the
EGFR deletion mutant (Fig. 7). These results were repro-
duced in four separate experiments. Taken together with the
inhibitor experiment, these findings indicate that EGFR
may play an important role in 4-AP-induced ERK activa-
tion.
DISCUSSION
K channel modulation and cellular function. Potassium
channel blockers, which inhibit repolarization to prolong
the cardiac action potentials, are commonly used for the
treatment of cardiac arrhythmias. Meanwhile, K channels
have been implicated in various functions in a variety of cell
types (19–21). Many agents that inhibit K channels have
been shown to suppress cellular proliferation (22,23), and
KBs have been used to suppress tumor cell proliferation
(19,22,24). The KBs have induced apoptosis in malignant
astrocytoma cell lines, but an anti-apoptotic effect of KBs
has also been reported (25). A recent report found that
2.5 mmol/l of 4-AP induced apoptosis in HepG2 cells in a
Ca2-dependent manner (26). This phenomenon can be
explained by the fact that elevation of the intracellular Ca2
concentration activates apoptosis-inducing phosphatases,
Ca2-dependent neutral proteinase, Ca2/Mg2-
dependent endonuclease and Ca2-dependent transglu-
taminase. Thus, the effect of K channel modulation on
cellular function may be quite different among different cell
types.
KB induces ERK activation. The main purpose of the
present study was to investigate whether pharmacologic
inhibition of K currents could influence the hypertrophic
signaling cascade in the cardiomyocytes of rats. This study
clearly showed that KBs evoked ERK phosphorylation,
possibly through activation of Pyk2 and EGFR in cardio-
myocytes, initiated by the entry of Ca2 through L-type
Ca2 channels. There are several lines of evidence to
suggest that the ERK pathway plays an important role in
mediating cardiac hypertrophy (5–7). Various hypertrophic
Figure 5. Involvement of epidermal growth factor receptor (EGFR) and Pyk2 in 4-aminopyridine (4-AP)-induced extracellular signal-regulated kinase
(ERK) activation. (A, B) Cardiomyocytes were pre-incubated with either KN62 (KN [calmodulin kinase II and IV inhibitor]) (10 mol/l), AG1478 (AG
[epidermal growth factor inhibitor]) (250 nmol/l), cytochalasin D (CyD [actin dimerization inhibitor]) (10 mol/l), calphostin C (Cal [PKC inhibitor])
(1 mol/l) or calmidazolium (CMZ [calmodulin inhibitor]) (50 mol/l) for 30 min and then treated with 4-AP for 15 min. Leukemia inhibitory factor
(LIF) was used as a positive control. AG1478 and cytochalasin D strongly blocked 4-AP-induced ERK activation, whereas the other agents did not. (C)
Densitometric analysis of the inhibitor experiment. Representative blot analyses are shown. All experiments were repeated at least five times and yielded
similar results. Data are presented as the mean value  SE. *p  0.01 vs. 4-AP alone.
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stimuli can induce activation of the ERK pathways. How-
ever, Thorborn et al. (27) reported that overexpression of
the active forms of Raf-1 and ERK does not cause the
sarcomeric organization typical of hypertrophic growth, and
Post et al. (28) reported that inhibition of MEK by
PD98059 did not suppress phenylephrine-induced sarco-
meric organization or atrial natriuretic peptide gene expres-
sion. Moreover, they showed that adenosine triphosphate
and carbachol activated the Raf-1/MEK/ERK cascade,
although neither of these reagents could cause cardiac
hypertrophy. These findings indicate that activation of ERK
alone was not sufficient for the induction of cardiac hyper-
trophy and hypertrophic gene expression, as well as suggest
that the role of this pathway was distinct from ligand to
ligand. The KBs are frequently used for the treatment of
cardiac arrhythmias and have never been reported to induce
cardiac hypertrophy in vivo. The effect of KBs on the
hypertrophy-mediating pathway in cardiomyocytes remains
unknown; however, it is possible that activation of ERK by
KBs does not directly cause cardiac hypertrophy.
Relationship between ERK activation and specific potas-
sium currents. In this study, we used four different kinds of
KBs. 4-Aminopyridine inhibits Ito and Ikur, but not Ikr and
Iks. Tetra-ethylammonium inhibits Ikr, Ikur and, partially,
Iks, but not Ito. E4031 only inhibits Ikr in cultured cardio-
myocytes (29). Quinidine blocks Ikur, Ikr, Iks (300 mol/l)
and Ito (30). Although they have different target channels,
all of these agents can prolong the APD. Because these
agents have different chemical structures, are not physio-
logic ligands and have different target channels, the mech-
anism of ERK activation may be caused by their common
effect of prolongation of action potentials. We suspected
that inhibition of specific K currents might not correlate
with KB-induced ERK activation.
Involvement of EGFR and Pyk2 in 4-AP-induced ERK
activation. The present study demonstrated that Ca2-
mediated signaling was critically involved in 4-AP-induced
ERK activation. Elevated intracellular levels of Ca2 can
trigger various signaling events, resulting in stimulation of
the MAPK pathway. In PC12 cells, Ca2 influx after
membrane depolarization by potassium chloride mediates
ligand-independent phosphorylation of EGFR in both a
CaMKII-dependent and -independent manner (10,31).
Figure 6. 4-Aminopyridine (4-AP) phosphorylates proline-rich tyrosine
kinase 2 (Pyk2) (A) and epidermal growth factor receptor (EGFR) (B) in
cardiomyocytes. Cardiomyocytes were stimulated with 4-AP for the
indicated times, and the tyrosine phosphorylation of Pyk2 and EGFR was
detected by immunoprecipitation-Western blot analysis. Endothelin
(ET-1) was used as a positive control agent. Anti-p-Tyr represents
anti-phosphotyrosine antibody. 4-Aminopyridine induced phosphorylation
of Pyk2 and EGFR at 5 and 10 min, respectively, in cardiomyocytes.
Figure 7. Effect of epidermal growth factor receptor (EGFR) deletion
mutant on 4-aminopyridine (4-AP)-induced extracellular signal-regulated
kinase (ERK) activation in cardiomyocytes. (Top) Cardiomyocytes were
co-transfected with HA-tagged ERK2 and either deletion mutant of
EGFR (pDN-EGFR), or empty plasmid (pcDNA), and treated with
4-AP for 15 min. The immunocomplex with anti-HA antibody was
precipitated on protein A-sepharose, and in vitro myelin basic protein
(MBP) kinase assay by ERK2 was performed, as described in Methods.
Data are presented as the mean value  SE of the results of five separate
experiments determined by densitometry. (Bottom) Densitometric analysis
of the inhibitory effect of dominant-negative EGFR on 4-AP-induced
myelin basic protein kinase activity of ERK. Data are presented as the
mean value  SE. *p  0.01 vs. 4-AP–treated cells transfected with the
empty vector. pDN-EGFR  dominant negative EGFR plasmid.
1561JACC Vol. 38, No. 5, 2001 Tahara et al.
November 1, 2001:1554–63 KB-Evoked Signals in Cardiomyocytes
Pyk2 is activated in PC12 cells by extracellular stimuli that
increase intracellular Ca2 in either a PKC-dependent or
-independent manner (16). Calmodulin-dependent kinases
are activated by an increase in intracellular Ca2 levels
mediated by Ca2 influx through L-type Ca2 channels
(32,33) or by Ca2 release from the intracellular store (34).
Therefore, we examined the downstream pathway of 4-AP-
induced augmentation of intracellular Ca2 leading to ERK
activation. The present study demonstrated that Pyk2 and
EGFR were involved in this activation of ERK (Fig. 8).
Because 4-AP only increases intracellular Ca2 levels, we
suspected that 4-AP-induced activation of Pyk2 may be
mediated, not by PKC, but only by Ca2. The molecular
mechanism of the activation of EGFR by 4-AP remains
unknown, but we supposed that Pyk2 might be involved in
EGFR activation, based on the finding that cytochalasin D,
but not calmidazolium, calphostin C nor KN62, inhibited
the activation of ERK.
Clinical implications. The KBs are known to prolong QT
intervals in the clinical setting, and many reports have
focused on the electrophysiologic side effects of high con-
centrations of KBs, such as torsade de pointes and even fatal
arrhythmias. To date, however, no clinical or experimental
studies have examined the biologic effect of these com-
pounds in cardiomyocytes. The present study has demon-
strated that, when we consider the side effects of KBs, we
should bear in mind not only the electrophysiologic effects,
but also the molecular effects, through various signaling
pathways. Further studies are required to determine the
effect of KBs on the cellular function in cardiomyocytes.
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